Related Experiment Video
Updated: Sep 9, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Optochemical control of G1 cell cycle by regulating CDK4/6 degradation
Tianyi Wang1,2,3,4, Yaming Zhang2,3,4, Yuwei Liu2,3,4
1Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou 510060, China.
Abstract:
Cancer progression is characterized by dysregulated G1/S phase transition mediated by CDK4/6-dependent Rb protein phosphorylation. Although CDK4/6 degraders show encouraging anti-tumor efficacy, it is highly desired to develop strategies to spatiotemporally control the release of active CDK4/6 degraders to further reduce adverse effects. In this study, we employ an optochemical strategy for CDK4/6 degradation by caging the CRBN ligand with a photoremovable protecting group. Light irradiation at 365 nm triggers photocleavage, thereby inducing CDK4/6 degradation via the ubiquitin-proteasome system. The resultant G1-phase arrest demonstrates spatial and temporal control over cell-cycle progression, reducing off-target effects of current therapies. This light-controlled system allows spatiotemporal CDK4/6 degradation and G1 cell-cycle arrest, providing a promising strategy to enhance specificity for cancer treatment and fundamental biological research.
Insights
Researchers developed a light-activated system to control cancer cell division. This optochemical strategy precisely degrades CDK4/6 proteins, offering targeted cancer therapy with fewer side effects.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cancer progression involves cell cycle dysregulation, specifically the G1/S phase transition, often driven by CDK4/6-dependent Rb protein phosphorylation.
- Current CDK4/6 degraders show anti-tumor potential but lack precise spatial and temporal control, leading to adverse effects.
Purpose of the Study:
- To develop an optochemical strategy for spatiotemporal control of CDK4/6 degraders.
- To investigate light-induced degradation of CDK4/6 proteins for targeted cancer therapy.
Main Methods:
- Employing an optochemical approach by caging a CRBN ligand with a photoremovable protecting group.
- Utilizing 365 nm light irradiation to trigger photocleavage and subsequent CDK4/6 degradation via the ubiquitin-proteasome system.
Main Results:
- Achieved light-induced, spatiotemporal degradation of CDK4/6 proteins.
- Demonstrated G1-phase cell-cycle arrest with spatial and temporal control.
- Showcased reduced off-target effects compared to current therapies.
Conclusions:
- The developed light-controlled system enables precise spatiotemporal degradation of CDK4/6.
- This strategy offers enhanced specificity for cancer treatment and applications in fundamental biological research.
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Negative Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

